Share Email Print
cover

Proceedings Paper

In vivo track the development of melanoma with the intrinsic third harmonic generation and two-photon fluorescence contrasts of melanin
Author(s): Pei-Chun Wu; Yu-Shing Chen; Tsung-Yuan Hsieh; Han-Wen Liu; Wen-Li Lin; Tzu-Ming Liu
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The understanding of the interaction between tumors and surrounding microenvironment in vivo is an important first step and basis for pathway-targeting cancer therapy. To in vivo observe the dynamic development of tumor cells and validate the efficacy of therapy in microscopic scales, people commonly performed multi-photon fluorescence microscopy through an invasive window chamber setup. However, under such system, the cancer cells can't be identified and long-term tracked without a fluorescence labeling. Exploiting the intrinsic third harmonic generation (THG) and two-photon fluorescence (2PF) contrasts of melanin, we demonstrated in vivo identification of melanoma and tracked its development without labeling. It was achieved with a least invasive femtosecond Cr:forsterite laser and a laser scanning nonlinear microscopy system with 3D sub-micron spatial resolution. Combined with molecular probes or reporters, we anticipate thus developed platform a powerful tool to reveal molecular insights of tumor microenvironments, enhance our understanding of tumor biology, and trigger new therapeutic approaches.

Paper Details

Date Published: 2 February 2012
PDF: 6 pages
Proc. SPIE 8233, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications IV, 82330O (2 February 2012); doi: 10.1117/12.906682
Show Author Affiliations
Pei-Chun Wu, National Taiwan Univ. (Taiwan)
Yu-Shing Chen, National Taiwan Univ. (Taiwan)
Tsung-Yuan Hsieh, National Taiwan Univ. (Taiwan)
Han-Wen Liu, National Taiwan Univ. (Taiwan)
Wen-Li Lin, National Taiwan Univ. (Taiwan)
Tzu-Ming Liu, National Taiwan Univ. (Taiwan)


Published in SPIE Proceedings Vol. 8233:
Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications IV
Samuel Achilefu; Ramesh Raghavachari, Editor(s)

© SPIE. Terms of Use
Back to Top